title: Role of Na(+), K(+)-ATPase in morphine-induced antinociception.
abstract: We evaluated the modulation by Na+,K+-ATPase inhibitors of morphine-induced antinociception in the tail-flick test and [3H]naloxone binding to forebrain membranes. The antinociception induced by morphine (1-32 mg/kg, s.c.) in mice was dose-dependently antagonized by ouabain (1-10 ng/mouse, i.c.v.), which produced a significant shift to the right of the morphine dose-response curve. The i.c.v. administration of three Na+,K+-ATPase inhibitors (ouabain at 0.1-100, digoxin at 1-1000, and digitoxin at 10-10000 ng/mouse) dose-dependently antagonized the antinociceptive effect of morphine (4 mg/kg, s.c.) in mice, with the following order of potency: ouabain > digoxin > digitoxin. This effect cannot be explained by any interaction at opioid receptors, since none of these Na+,K+-ATPase inhibitors displaced [3H]naloxone from its binding sites, whereas naloxone did so in a concentration-dependent manner. The antinociception induced by morphine (5 mg/kg, s.c.) in rats was antagonized by the i.c.v. administration of ouabain at 10 ng/rat, whereas it was not significantly modified by intrathecally administered ouabain (10 and 100 ng/rat). These results suggest that the activation of Na+,K+-ATPase plays a role in the supraspinal, but not spinal, antinociceptive effect of morphine.
authors.affiliation: Department of Pharmacology and Neuroscience Institute, Faculty of Medicine, University of Granada, Granada, Spain.
authors.forename: Willias
authors.initials: W
authors.lastname: Masocha
authors.forename: Gyongyi
authors.initials: G
authors.lastname: Horvath
authors.forename: Ahmad
authors.initials: A
authors.lastname: Agil
authors.forename: Maria
authors.initials: M
authors.lastname: Ocana
authors.forename: Esperanza
authors.initials: E
authors.lastname: Del Pozo
authors.forename: Margit
authors.initials: M
authors.lastname: Szikszay
authors.forename: José M
authors.initials: JM
authors.lastname: Baeyens
mesh_terms: D000698:Analgesia; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D004347:Drug Interactions; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology*; D010146:Pain / Q000517:prevention & control; D051381:Rats; D017208:Rats, Wistar; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors* / Q000502:physiology
chemical_list: D000701:Analgesics, Opioid; D009270:Naloxone; D010042:Ouabain; D009020:Morphine; D000254:Sodium-Potassium-Exchanging ATPase